{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:55:18Z","timestamp":1778122518568,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LSHB-CT-2004-503243"],"award-info":[{"award-number":["LSHB-CT-2004-503243"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ejogrb.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T21:00:46Z","timestamp":1348693246000},"page":"10-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cell-free fetal DNA and adverse outcome in low risk pregnancies"],"prefix":"10.1016","volume":"166","author":[{"given":"Werner","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Gutensohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Emons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Legler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2012.09.006_bib0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mob.2001.109594","article-title":"Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia","volume":"184","author":"Zhong","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","article-title":"Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia","volume":"45","author":"Lo","year":"1999","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0015","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/clinchem\/48.12.2141","article-title":"Fetal DNA clearance from maternal plasma is impaired in preeclampsia","volume":"48","author":"Lau","year":"2002","journal-title":"Clinical Chemistry"},{"issue":"10","key":"10.1016\/j.ejogrb.2012.09.006_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2350-10-120","article-title":"Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia","volume":"21","author":"Lazar","year":"2009","journal-title":"BMC Medical Genetics"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/clinchem\/47.1.137","article-title":"Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia","volume":"47","author":"Leung","year":"2001","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/PRG-120002911","article-title":"The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia","volume":"21","author":"Zhong","year":"2002","journal-title":"Hypertension in Pregnancy"},{"issue":"472","key":"10.1016\/j.ejogrb.2012.09.006_bib0035","first-page":"e1","article-title":"First-trimester maternal plasma cell-free fetal DNA and preeclampsia","volume":"201","author":"Sifakis","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0040","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1537-2995.2008.01843.x","article-title":"The determination of the fetal RhD status from maternal plasma for decision making on Rh prophylaxis is feasible","volume":"48","author":"M\u00fcller","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/pd.1783","article-title":"Workshop report on the extraction of fetal DNA from maternal plasma","volume":"27","author":"Legler","year":"2007","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0050","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/pd.2889","article-title":"Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days","volume":"31","author":"M\u00fcller","year":"2011","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/clinchem\/48.4.650","article-title":"Hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum","volume":"48","author":"Swinkels","year":"2002","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pd.788","article-title":"Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients","volume":"24","author":"Farina","year":"2004","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/pd.1504","article-title":"Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies","volume":"26","author":"Smid","year":"2006","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2009.06.016","article-title":"Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator\u2014preliminary report","volume":"146","author":"Karina","year":"2009","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/8.6.501","article-title":"Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia","volume":"8","author":"Hahn","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pd.1645","article-title":"Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia","volume":"27","author":"Crowley","year":"2007","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1081\/PRG-120021062","article-title":"Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia","volume":"22","author":"Byrne","year":"2003","journal-title":"Hypertension in Pregnancy"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pd.1513","article-title":"A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome","volume":"26","author":"Bauer","year":"2006","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2012.09.006_bib0095","series-title":"Practical statistics for medical research","author":"Altman","year":"1991"},{"issue":"98","key":"10.1016\/j.ejogrb.2012.09.006_bib0100","first-page":"e1","article-title":"Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction","volume":"200","author":"Alberry","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512004137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512004137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:27:19Z","timestamp":1759555639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211512004137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0301211512004137"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.09.006","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free fetal DNA and adverse outcome in low risk pregnancies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}